Power Law company profile

Hybio Pharmaceutical

Biotech & Life Sciences · Shenzhen, China · Founded 1998 · IPO 2011 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$2.80B

Market cap · Apr/2026

Revenue

$133M

Latest reported FY

Investors

2 investors on Hybio Pharmaceutical's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage

Global footprint

Web traffic by country

630 monthly visits
across markets

🇺🇸 United States95.2%

Top 1 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo